Australia - English - Department of Health (Therapeutic Goods Administration)

wm dr rj & l lindqvist - 33600 - wheelchair accessory/component, - with the help of therapists, parents and other care givers, miller?s developed a wide variety of modular hardware that was easily adaptable and very durable to help customise wheelchair seating, posture and support. eventually other dme vendors asked about these products for their customers. soon, miller?s special products division (the original name) developed a national reputation for fast, dependable adaptive seating products.

Canada - English - Health Canada

lite & rite inc. - ephedra; willow bark - tablet - 280mg; 280mg - ephedra 280mg; willow bark 280mg - herbs and natural products

United States - English - NLM (National Library of Medicine)

sonchin biomedical cosmetics corp. - benzalkonium chloride (unii: f5um2km3w7) (benzalkonium - unii:7n6jud5x6y) - antibacterial - helps reduce bacteria on the skin - recommended for repeated use - on children less than 2 months of age - on open skin wounds - around eyes - in ears and mouth if irritation or rash occurs.

United States - English - NLM (National Library of Medicine)

ca-botana international - menthol (unii: l7t10eip3a) (menthol - unii:l7t10eip3a) - uses: for temporary relief of minor aches and pains of muscles and joints associated with. simple aches. back aches. arthritis.strains.bruises.sprains. apply generous amount of gel directly affected area massage into painful area until thoroughly absorbed into skin

United States - English - NLM (National Library of Medicine)

ca-botana international - menthol (unii: l7t10eip3a) (menthol - unii:l7t10eip3a) - uses: for temporary relief of minor aches and pains of muscles and joints associated with. simple aches. back aches. arthritis.strains.bruises.sprains. apply generous amount of gel directly affected area massage into painful area until thoroughly absorbed into skin

Australia - English - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - ondansetron hydrochloride dihydrate, quantity: 5 mg (equivalent: ondansetron, qty 4 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; lactose monohydrate; magnesium stearate; pregelatinised maize starch; sodium starch glycollate; colloidal anhydrous silica; titanium dioxide; hypromellose; purified talc; iron oxide yellow; macrogol 400 - prevention and treatment of nausea and vomiting induced by cytotoxic therapy and radiotherapy.

Australia - English - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - ondansetron hydrochloride dihydrate, quantity: 10 mg (equivalent: ondansetron, qty 8 mg) - tablet, film coated - excipient ingredients: lactose monohydrate; pregelatinised maize starch; magnesium stearate; colloidal anhydrous silica; microcrystalline cellulose; sodium starch glycollate; titanium dioxide; hypromellose; purified talc; iron oxide yellow; macrogol 400 - prevention and treatment of nausea and vomiting induced by cytotoxic therapy and radiotherapy.

Australia - English - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - quetiapine fumarate, quantity: 345.396 mg (equivalent: quetiapine, qty 300 mg) - tablet, film coated - excipient ingredients: lactose monohydrate; microcrystalline cellulose; calcium hydrogen phosphate dihydrate; colloidal anhydrous silica; sodium starch glycollate type a; magnesium stearate; povidone; titanium dioxide; hypromellose; macrogol 400 - bipolar disorder. adults = maintenance treatment of bipolar i disorder, as monotherapy, or in combination with lithium or sodium valproate, for the prevention of relapse/recurrence of manic, depressive or mixed episodes. = treatment of depressive episodes associated with bipolar disorder (see dosage and administration). = treatment of acute mania associated with bipolar i disorder as monotherapy or in combination with lithium or sodium valproate.,children/adolescents aged 10 to 17 years,= monotherapy treatment of acute mania associated with bipolar i disorder,schizophrenia. (adults and adolescents aged 13 to 17 years) = treatment of schizophrenia.

Australia - English - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - quetiapine fumarate, quantity: 230.264 mg (equivalent: quetiapine, qty 200 mg) - tablet, film coated - excipient ingredients: lactose monohydrate; sodium starch glycollate type a; povidone; calcium hydrogen phosphate dihydrate; magnesium stearate; colloidal anhydrous silica; microcrystalline cellulose; titanium dioxide; hypromellose; macrogol 400 - bipolar disorder. adults = maintenance treatment of bipolar i disorder, as monotherapy, or in combination with lithium or sodium valproate, for the prevention of relapse/recurrence of manic, depressive or mixed episodes. = treatment of depressive episodes associated with bipolar disorder (see dosage and administration). = treatment of acute mania associated with bipolar i disorder as monotherapy or in combination with lithium or sodium valproate.,children/adolescents aged 10 to 17 years,= monotherapy treatment of acute mania associated with bipolar i disorder,schizophrenia. (adults and adolescents aged 13 to 17 years) = treatment of schizophrenia.

Australia - English - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - quetiapine fumarate, quantity: 115.132 mg (equivalent: quetiapine, qty 100 mg) - tablet, film coated - excipient ingredients: magnesium stearate; calcium hydrogen phosphate dihydrate; microcrystalline cellulose; lactose monohydrate; sodium starch glycollate type a; povidone; colloidal anhydrous silica; titanium dioxide; hypromellose; iron oxide yellow; macrogol 400 - bipolar disorder. adults = maintenance treatment of bipolar i disorder, as monotherapy, or in combination with lithium or sodium valproate, for the prevention of relapse/recurrence of manic, depressive or mixed episodes. = treatment of depressive episodes associated with bipolar disorder (see dosage and administration). = treatment of acute mania associated with bipolar i disorder as monotherapy or in combination with lithium or sodium valproate.,children/adolescents aged 10 to 17 years,= monotherapy treatment of acute mania associated with bipolar i disorder,schizophrenia. (adults and adolescents aged 13 to 17 years) = treatment of schizophrenia.